Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
Inflammation|September 1, 1980
Effect of auranofin on antibody-dependent cellular cytotoxicity (ADCC) mediated by rat peripheral blood polymorphonuclear leukocytes and mononuclear cellsM J DiMartino, D T WalzInflammation|June 1, 1977
Inhibition of lysosomal enzyme release from rat leukocytes by auranofin. A new chrysotherapeutic agentM J Dimartino, D T WalzCellular Immunology|November 1, 1986
Macrophage activation in rat models of inflammation and arthritis: determination of markers of stages of activationW J Johnson, M J DiMartino, N HannaThe Journal of Rheumatology. Supplement|July 1, 1982
Comparative pharmacology and biological effects of different gold compoundsD T Walz, M J DiMartino, D E GriswoldScandinavian Journal of Rheumatology. Supplement|January 1, 1983
The pharmacological profile of auranofin, an orally active gold compoundD T Walz, M J DiMartino, D E GriswoldThe Journal of Rheumatology. Supplement|January 1, 1979
Immunopharmacology of auranofin and gold sodium thiomalate: effects on humoral immunityD T Walz, M J DiMartino, D E GriswoldThe Journal of Rheumatology. Supplement|July 1, 1982
Mechanisms of action of auranofin: effects on humoral immune responseD T Walz, M J Dimartino, D E GriswoldAgents and Actions|August 1, 1987
Effect of antiarthritic drugs on the enhanced interleukin-1 (IL-1) production by macrophages from adjuvant-induced arthritic (AA) ratsM J DiMartino, W J Johnson, B Votta, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1987
Effect of auranofin treatment on aberrant splenic interleukin production in adjuvant arthritic ratsJ C Lee, M J Dimartino, B J Votta, et al.Agents and Actions|August 1, 1987
The pharmacology of arachidonic acid-induced rat paw edemaM J DiMartino, G K Campbell, C E Wolff, et al.Pageof 4